Dr Martens holds guidance on healthy order book; UK trade still tough.
Iconic UK shoemaker Dr Martens held annual guidance and said it continued to see positive trading in its Americas direct to consumer operations, driven by full price sales, although its UK business continued to experience a challenging trading backdrop.
Dr. Martens
10 July 2025 07:51:50
Source: Sharecast
In a trading update on Thursday, the company said autumn/winter order books globally were healthy, with EMEA up year-on-year, while the Americas was broadly in line year-on-year and based on a much wider product range than previously. Dr Martens added that its earnings performance would be second-half weighted.
Its Asia-Pacific business “continues to show good growth, with a particularly strong performance in South Korea driven by our well-established shoes category here”.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
